MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer

Overview of attention for article published in Frontiers in oncology, September 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 6,531 followers.

New research: MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer: Although MASTL (microtubule-associated serine/threonine kinase-like) is an attractive… https://t.co/PS

04 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.